Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10008390 | Oral Oncology | 2018 | 8 Pages |
Abstract
Positive TrkA and/or CD271 staining predicts worse outcomes. Patients may benefit from aggressive RT for local control and symptom improvement. Future research is needed to identify the potential for anti-nerve growth factor therapies in CPNI.
Keywords
Trk ANGFRFOXP3IPNISCCCrtLRRBCCNEDCSMPNIMRIImagingMagnetic resonance imagingcomputed tomographyforkhead box P3Perineural invasionRadiotherapyImmunohistochemical stainingSkin cancerHead and neck cancerChemoradiotherapySurgeryLocoregional recurrencenerve growth factorCancer-specific mortalityno evidence of diseaseBasal cell carcinomaSquamous cell carcinomaSymptom controlnerve growth factor receptor
Related Topics
Health Sciences
Medicine and Dentistry
Dentistry, Oral Surgery and Medicine
Authors
Jie Jane Chen, Jeremy P. Harris, Christina S. Kong, John B. Sunwoo, Vasu Divi, Kathleen C. Horst, Sumaira Z. Aasi, S. Tyler Hollmig, Wendy Y. Hara,